Press Releases Year All News202020192018201720162015 Lonza and Forty Seven Inc. Announce Strategic Manufacturing Agreement for Immuno-Oncology Therapeutic Antibody Pipeline October 13, 2016 Forty Seven Inc. named as one of FierceBiotech’s “Fierce 15” Biotech Companies of 2016 September 19, 2016 Heart disease: Death-defying plaque cells. Tabas, Nature 2016 doi:10.1038/nature18916 July 20, 2016 Immuno-oncologists eye up macrophage targets. Morrison, Nature Reviews Drug Discovery 2016 15, 373-374. June 1, 2016 Forty Seven Inc. Completes $75M Series A Financing and Licenses Technology from Stanford University to Advance Next Generation Immuno-Oncology Programs February 24, 2016